Netherlands· NL-2706e8ebe77f
Abacavir/Lamivudine Viatris 600 mg/300 mg, filmomhulde tabletten
A lamivudine and abacavir product containing abacavirsulfaat + lamivudine 0-water, registered in Netherlands by Viatris Limited. The same ATC class is registered in 14 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Lamivudine and abacavir is registered in 14 of 19 countries.
Countries holding a registration under ATC J05AR02 (lamivudine and abacavir), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 9 of them publish a price we can compare per daily dose
Lamivudine and abacavir · ATC J05AR02
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- ABACAVIRSULFAAT + LAMIVUDINE 0-WATER
- Manufacturer
- Viatris Limited
- Country
- Netherlands (NL)
- ATC code
- J05AR02
- ATC class
- Lamivudine and abacavir
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id118678
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
2 interactions on record for lamivudine and abacavir.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Lamivudine and abacavir · interactions on record
2 records
2 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Lamivudine and abacavir in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainABACAVIR/LAMIVUDINA ACCORD 600 MG/300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGAccord Healthcare S.L.U.
- United KingdomAbacavir 600mg / Lamivudine 300mg tabletsLupin Healthcare (UK) Ltd
- GermanyAbacavir/Lamivudin AlAliud Pharma Gmbh
- FinlandAbacavir/Lamivudin MylanMylan AB
- FranceABACAVIR/LAMIVUDINE ACCORD 600 mg/300 mg, comprimé pelliculéACCORD HEALTHCARE FRANCE
- United StatesAbacavir and LamivudineCipla USA Inc.
- SwedenAbacavir/Lamivudine Accord 600 mg/300 mg Filmdragerad tablettAccord Healthcare B.V.
- CanadaAPO-ABACAVIR-LAMIVUDINEAPOTEX INC
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Abacavir/Lamivudin Ratiopharm, Abacavir/Lamivudin Sandoz
- Belgium · Abacavir/Lamivudine Viatris
- Bulgaria · Abacavir/Lamivudine Viatris, Абакавир/Ламивудин Майлан
- Cyprus · Kivala
- Germany · Abacavir/Lamivudin Al, Abacavir/Lamivudin Aurobindo
- Denmark · Abacavir/Lamivudin Medical Valley, Abacavir/Lamivudin Mylan
- Estonia · Abacavir/Lamivudine Auxilia, Abacavir/Lamivudine Mylan
- Spain · Abacavir/Lamivudina Aurovitas, Abacavir/Lamivudina Dr. Reddys
- Finland · Abacavir/Lamivudin Mylan, Abacavir/Lamivudin Viatris
- France · Abacavir / Lamivudine Biogaran, Abacavir/Lamivudine Arrow
- United Kingdom (Northern Ireland) · Abacavir/Lamivudin Sandoz, Abacavir/Lamivudine Accord
- Greece · Abacavir+lamivudine Mylan Pharma, Varistren
- Hungary · Abacavir/Lamivudine Teva
- Ireland · Abacavir/Lamivudine Mylan, Abacavir/Lamivudine Viatris
- Iceland · Kivexa
- Italy · Abacavir E Lamivudina Aurobindo, Abacavir E Lamivudina Sun
- Liechtenstein · Kivexa
- Lithuania · Abacavir / Lamivudine Auxilia, Abacavir/Lamivudine Accord
- Luxembourg · Abacavir/Lamivudine Viatris
- Latvia · Abacavir/Lamivudine Accord, Abacavir/Lamivudine Mylan
- Norway · Abacavir/Lamivudin Mylan, Abacavir/Lamivudine Viatris
- Poland · Abacavir + Lamivudine Sandoz
- Portugal · Abacavir + Lamivudina Aurovitas, Abacavir + Lamivudina Farmoz
- Romania · Abacavir/Lamivudină, Abacavir/Lamivudină Mylan
- Sweden · Abacavir/Lamivudine Accord, Abacavir/Lamivudine Glenmark
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e79c9d1b-6874-4183-855b-4fc3acf4de6c GET /v1/drugs/e79c9d1b-6874-4183-855b-4fc3acf4de6c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Filmomhulde tablet",
"route": "Oraal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h118678_smpc.pdf",
"strength": null,
"atc_label": "Lamivudine And Abacavir",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg118678",
"excipients": [
"CELLULOSE, MICROKRISTALLIJN (E 460(i))",
"CROSPOVIDON (E 1202)",
"HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
"MACROGOL 400",
"MAGNESIUMSTEARAAT (E 470b)",
"POLYSORBAAT 80 (E 433)",
"SILICIUMDIOXIDE (E 551)",
"TALK (E 553b)",
"TITAANDIOXIDE (E 171)"
],
"substances": [
"ABACAVIRSULFAAT",
"LAMIVUDINE 0-WATER"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h118678.pdf",
"authorised_at": "2017/10/04",
"procedure_number": "AT/H/0920/001",
"dispensing_status": "Uitsluitend recept",
"registration_number": "118678",
"additional_monitoring": "N"
}See everything about lamivudine and abacavir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.